ArticleOncoimmunology2021

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation.

Ryan M Reyes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.